dimethyldioctadecylammonium has been researched along with Chagas Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afchain, D; Bahr, G; Chedid, L; Moddaber, F; Scott, MT | 1 |
1 other study(ies) available for dimethyldioctadecylammonium and Chagas Disease
| Article | Year |
|---|---|
Adjuvant requirements for protective immunization of mice using a Trypanosoma cruzi 90K cell surface glycoprotein.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antibody Specificity; Antigens, Surface; Chagas Disease; Glycoproteins; Hypersensitivity, Delayed; Immunization; Mice; Mice, Inbred CBA; Propionibacterium acnes; Quaternary Ammonium Compounds; Saponins; Squalene; Trypanosoma cruzi | 1984 |